No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

LaunchPad Medical Wins a $2.5 Million NIH Grant to Improve Cranial Procedures

This Grant will Enable to Company to Complete its Pre-Clinical Research and Make Key Preparations to Start a Clinical Trial

Editor: What To Know

  • Foley, the lead author of this publication and Professor of Neurosurgery at the University of Tennessee Health Science Center as well as Chairman of the Semmes-Murphey Clinic, said “This research demonstrates the ability of Tetranite to safely and effectively repair cranial defects without the use of conventional hardware.
  •   In fact, the study showed that Tetranite produces a better, stronger bond between a bone flap and the surrounding skull than do plates and screws, with fewer complications.
  •   The process produces a kerf line, or continuous gap between the bone flap and the rest of the skull.

LaunchPad Medical, Inc. announced that it has been awarded a $2.5 million Direct-to-Phase II Small Business Innovation Research (SBIR) grant (1R44NS115386) from the National Institute of Neurological Disorders and Stroke to advance the development of Tetranite®, its bone adhesive biomaterial technology, to improve cranial flap fixation procedures.

LaunchPad Medical notes the clinical use of this product is expected to enhance bone healing, reduce infection rates, and improve the cosmetic outcome of these procedures for patients while eliminating the need for metal fixation hardware.

Brain surgery often involves performing a craniotomy, a procedure by which a portion of the skull is temporarily removed using bone cutting instruments.   A specialized drill cuts the skull allowing the surgeon to circumscribe a “flap” of bone enabling access to the brain.  The process produces a kerf line, or continuous gap between the bone flap and the rest of the skull.  As part of the surgical closure process, the flap is secured into place with cranial plates and screws.  The kerf line is not typically sealed, which may compromise the ability of the flap to integrate with the surrounding bone.  An open kerf line can also leave a pathway for the leakage of cerebrospinal fluid (“CSF”), which increases the overall risk of infection.

“Infection rates in published literature range up to 21%, which can result in meningitis, subdural empyema, or cerebral abscesses,” said Brian Hess, CEO of LaunchPad Medical.  “CSF leaks increase the risk of infection by as much as 13 times and have been reported to almost double the healthcare cost of the original procedure.”

In a prior large animal study consisting of 41 skeletally mature sheep, biomechanical testing was performed to show both the immediate and sustained adhesive strength of Tetranite.  Histological and histomorphometric analysis was also conducted to evidence the osteointegration of the cranial flaps over a two-year period.  The results of this study were recently published in the Journal of Neurosurgery.  Dr. Kevin T. Foley, the lead author of this publication and Professor of Neurosurgery at the University of Tennessee Health Science Center as well as Chairman of the Semmes-Murphey Clinic, said “This research demonstrates the ability of Tetranite to safely and effectively repair cranial defects without the use of conventional hardware.  In fact, the study showed that Tetranite produces a better, stronger bond between a bone flap and the surrounding skull than do plates and screws, with fewer complications.”

“Having worked with this material as part of LaunchPad Medical’s pre-clinical research team, I foresee the use of Tetranite in many surgical applications such as cranial bone flap fixation,” said Eric J. Woodard, Chief of Neurosurgery at the New England Baptist Hospital.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy